Latest Breaking News On - Nitrasetherapeutics inc - Page 1 : comparemela.com

/PRNewswire/ Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research agreement.

United statesAl iskandariyahUnited kingdomMission bayWestern australiaPierre beaurangNitrome biosciencesJin liMission bay capitalNitrasetherapeutics incPrnewswire shanghai stock exchangeDementia discovery fundTherapeutics incHitgen incBristol myers squibbMichaelj fox foundation for parkinson research